Atlas Trials

Study of Pemetrexed and Bevacizumab in Patients With Head and Neck Cancer

Clinical trial NCT00222729 · COMPLETED

Trial details

NCT number
NCT00222729
Sponsor
University of Pittsburgh
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Cancer
Start date
2005-11-01
Primary completion
2013-10-01
Enrollment
42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.